Part D Payment for Drugs for Beneficiaries Receiving Renal Dialysis Services
Guidance for Part D sponsors to prospectively determine payment responsibility for drugs included in the seven categories that may be used for the treatment of End-Stage Renal Disease (ESRD) for ESRD beneficiaries receiving renal dialysis services.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: November 14, 2014
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.